Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs.
about
The role of infections in autoimmune diseaseMolecular mimicry as an inducing trigger for CNS autoimmune demyelinating diseaseInfluence of the Theiler's virus L* protein on macrophage infection, viral persistence, and neurovirulence.Anti-CCL2 treatment inhibits Theiler's murine encephalomyelitis virus-induced demyelinating diseaseDirect comparison of demyelinating disease induced by the Daniel's strain and BeAn strain of Theiler's murine encephalomyelitis virus.Spontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosis.Role of individual T-cell epitopes of Theiler's virus in the pathogenesis of demyelination correlates with the ability to induce a Th1 response.High numbers of viral RNA copies in the central nervous system of mice during persistent infection with Theiler's virus.CD28 costimulatory blockade exacerbates disease severity and accelerates epitope spreading in a virus-induced autoimmune disease.Protective and detrimental roles for regulatory T cells in a viral model for multiple sclerosisCentral neuroinvasion and demyelination by inflammatory macrophages after peripheral virus infection is controlled by SHP-1.A spontaneous low-pathogenic variant of Theiler's virus contains an amino acid substitution within the predominant VP1(233-250) T-cell epitope.Theiler's virus infection of primary cultures of bone marrow-derived monocytes/macrophagesPreferential induction of protective T cell responses to Theiler's virus in resistant (C57BL/6 x SJL)F1 miceInfection with Theiler's murine encephalomyelitis virus directly induces proinflammatory cytokines in primary astrocytes via NF-kappaB activation: potential role for the initiation of demyelinating disease.Transgenic expression of viral capsid proteins predisposes to axonal injury in a murine model of multiple sclerosisThe relationship between viral RNA, myelin-specific mRNAs, and demyelination in central nervous system disease during Theiler's virus infection.Viral infection and dissemination through the olfactory pathway and the limbic system by Theiler's virusThe predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease.Picornavirus-specific CD4+ T lymphocytes possessing cytolytic activity confer protection in the absence of prophylactic antibodiesGamma interferon is critical for resistance to Theiler's virus-induced demyelination.Theiler's murine encephalomyelitis virus kills restrictive but not permissive cells by apoptosis.In vivo administration of interleukin-2 protects susceptible mice from Theiler's virus persistence.Major linear antibody epitopes and capsid proteins differentially induce protective immunity against Theiler's virus-induced demyelinating disease.Role of macrophages during Theiler's virus infection.Monoclonal antibody to Theiler's murine encephalomyelitis virus defines a determinant on myelin and oligodendrocytes, and augments demyelination in experimental allergic encephalomyelitis.Analysis of antibody responses to predominant linear epitopes of Theiler's murine encephalomyelitis virus.Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.The 5' noncoding sequences from a less virulent Theiler's virus dramatically attenuate GDVII neurovirulenceIdentification of a locus on mouse chromosome 3 involved in differential susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease.Survival of athymic (nu/nu) mice after Theiler's murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibodyModulation of macrophage infiltration and inflammatory activity by the phosphatase SHP-1 in virus-induced demyelinating diseaseTransition from acute to persistent Theiler's virus infection requires active viral replication that drives proinflammatory cytokine expression and chronic demyelinating disease.Genomic regions of neurovirulence and attenuation in Theiler murine encephalomyelitis virus.Theiler's murine encephalomyelitis virus infection of SJL/J and C57BL/6J mice: Models for multiple sclerosis and epilepsy.Differentiation of M1 myeloid precursor cells into macrophages results in binding and infection by Theiler's murine encephalomyelitis virus and apoptosis.Identification of a major T-cell epitope within VP3 amino acid residues 24 to 37 of Theiler's virus in demyelination-susceptible SJL/J mice.Modulation of viral replication in macrophages persistently infected with the DA strain of Theiler's murine encephalomyelitis virus.Receptors for Theiler's murine encephalomyelitis virus: characterization by using rabbit antiviral antiserum.Virus persistence in an animal model of multiple sclerosis requires virion attachment to sialic acid coreceptors
P2860
Q22242631-59F0C002-A2AB-43E4-9241-17AAF3E9BEE3Q24613288-9134CD4D-0160-4679-BB28-608112B2E1B1Q33604509-6BC3D5FF-3E53-47BE-AE25-548B7DC53F74Q33693006-DD48C3B1-F0BC-46AB-8FAB-E4857FA76EA6Q33746029-C30A8477-45FE-4C13-BBDA-C645AA37D473Q33757272-6D69C209-0FDA-40E8-9E39-F3279CD82161Q33785859-25A3DB0F-3376-4015-9762-C9C8587E5875Q33852695-54C9131A-1809-47F7-B712-6C2DA0C99EA0Q33873833-F158817E-302F-4C56-844A-BFA26AA27CE9Q33901171-C03378DC-ED80-4B19-B33D-AC49E87E5FCAQ33905233-E91B7FB2-BB5B-44D1-A284-90450635C88EQ34069130-FB8DA21D-023D-4DFB-BCAB-7F4BDB1D590AQ34350897-FA6006F6-4F60-4A05-B206-5F2E7475ECE3Q34742990-2722BA16-180C-4B06-A045-7D609F887DECQ34996480-544B8310-5BFB-440A-91D5-35F50A6CBD10Q35113367-6D034F72-D5E4-4657-8F96-4723A7A238E2Q35812207-6200C47B-44A4-4B8B-B505-9745ADC351F1Q35832886-986CB530-F208-4E57-9EBF-634C7E4C198EQ35838043-B8808BB8-1860-46C3-A137-A44E34024E53Q35844880-16FD3423-AAC0-4DF9-A0C3-3F16154DA71EQ35851386-66EEE41B-C48A-458D-A6A8-4A0FF5C65209Q35870294-46E3EA42-AB71-4637-B329-112FF609DB11Q35876046-9C3BF665-41F8-4137-A3E2-7768847E851EQ35881226-4D8EBFE7-372F-401A-8CD2-6822AE6ED18FQ35882001-C04D1270-CD05-4C73-8FB6-4399EA3B9B8AQ36351287-D8836C58-07D9-4439-ABEB-E73F9D9672EDQ36633721-D150CAF2-CB3E-42F4-B25F-391F30C0F3AEQ36642040-883FC171-7827-4F04-8BCE-E370C527A4CAQ36797378-F90A9AAA-C6A2-4E3A-8B65-7EAE9B2E5479Q36800803-97983309-F3DF-4C7A-A51E-6B251D204D70Q36827367-85FBD89E-6572-4C1E-8885-46ACFF4F81ACQ37033330-39FC086B-9025-4D76-9EB7-C1E865E83192Q37596941-DE67E8E5-CDAD-4A96-9064-AB8EE15FE83EQ37683175-242801E0-8554-4022-89FD-E10A2A313F48Q39150957-C325002B-6147-4679-9B7B-B78AD3493371Q39550054-B6317CAE-A25F-423D-B28E-81D5694B4807Q39872503-8C1401DB-3916-4AA2-B6E5-AED9F785888AQ39953842-9F711306-581F-483A-A262-475072B715E9Q40130970-DC122295-F7EE-48FF-8573-4431102AC27BQ40530718-7DEA996A-E96E-40EE-A8B1-CB84304A871C
P2860
Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh-hant
name
Characterization of Theiler's ...... rrelation with clinical signs.
@en
Characterization of Theiler's murine encephalomyelitis virus
@nl
type
label
Characterization of Theiler's ...... rrelation with clinical signs.
@en
Characterization of Theiler's murine encephalomyelitis virus
@nl
prefLabel
Characterization of Theiler's ...... rrelation with clinical signs.
@en
Characterization of Theiler's murine encephalomyelitis virus
@nl
P2093
P1476
Characterization of Theiler's ...... orrelation with clinical signs
@en
P2093
P304
P407
P577
1986-02-01T00:00:00Z